To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.
Spécifications
- Protein/peptide type:Recombinant
- Source:HEK293 cells
- Species:Human
- Size:0.025 mg
- Tag sequence:His Tag
- Biological activity:Measured by its ability to inhibit trypsin cleavage of a fluorogenic peptide substrate, Mca - RPKPVE - Nval - WRK(Dnp) - NH2.
- Protein synonyms:Glia-derived nexin|PI7|SERPINE2|GDN|SerpinE2|Peptidase inhibitor 7|PN-1|Serpin E2|PI-7|Protease nexin 1
- Protein/peptide name:Serpin E2
- Purity:>92% as determined by SDS-PAGE.
- Molecular weight:42.7 kDa
- Formulation:Lyophilized, 20 mM NaAc, 100 mM NaCl, PH6.5
- Tested applications:Western Blot
- Cat. no.:10798-350
- Supplier No.:96-683
Spécifications
A propos de cet article
SERPINE2 is also known as Glia-derived nexin (GDN), Peptidase inhibitor 7 (PI7), Protease nexin 1(PN1). SERPINE2 is a secreted glycoprotein which belongs to the serpin family. SerpinE1 is the primary physiological inhibitor of the two plasminogen activators urokinase (uPA) and tissue plasminogen activator (tPA). PAI-1 / GDN is also implicated in adipose tissue development. It suggests that PAI-1 inhibitors serve in the control of atherothrombosis. Defects in Serpin E1 / PN1 are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1 deficiency) which is characterized by abnormal bleeding due to SerpinE1 defect in the plasma.